The NIH Loosens Grip on Gene Therapy Trials
The NIH Loosens Grip on Gene Therapy Trials
The agency proposes ceding its scrutiny of these studies to the FDA.
The NIH Loosens Grip on Gene Therapy Trials
The NIH Loosens Grip on Gene Therapy Trials

The agency proposes ceding its scrutiny of these studies to the FDA.

The agency proposes ceding its scrutiny of these studies to the FDA.

clinical trials, FDA, cancer, biobusiness
Drug Approval Could Boost Research on Marijuana Treatment for Autism
Drug Approval Could Boost Research on Marijuana Treatment for Autism
Jessica Wright | Aug 17, 2018
Epidiolex, a cannabis-derived medicine for epilepsy, will prompt federal regulatory changes that could crack open access to study the plant.
Elephants Revived a “Zombie” Gene that May Fend Off Cancer
Elephants Revived a “Zombie” Gene that May Fend Off Cancer
Kerry Grens | Aug 15, 2018
DNA damage kick-starts what was once a defunct duplicated gene, which kills off injured cells.
Jury Finds Monsanto’s Roundup Responsible for Man’s Cancer
Jury Finds Monsanto’s Roundup Responsible for Man’s Cancer
Sukanya Charuchandra | Aug 13, 2018
A San Francisco court levels $289 Million in damages against the pesticide maker.
FDA Approves Oral Drug for Fabry Disease
FDA Approves Oral Drug for Fabry Disease
Ashley Yeager | Aug 13, 2018
The medicine increases the activity of a deficient enzyme in certain patients with the condition.
Effort to Reproduce Cancer Studies Scales Down to 18 Papers
Effort to Reproduce Cancer Studies Scales Down to 18 Papers
Diana Kwon | Aug 1, 2018
The Reproducibility Project: Cancer Biology initially aimed to replicate the results of 50 high-impact research articles.
The Superpowers of Genetically Modified Pigs
The Superpowers of Genetically Modified Pigs
Kerry Grens | Aug 1, 2018
Scientists have engineered swine that pollute less, fend off disease, and produce more meat, but you won’t find them outside experimental farms . . . yet.
Opinion: Learning from Immunotherapy’s Recent Failures
Opinion: Learning from Immunotherapy’s Recent Failures
Luis Felipe Campesato | Aug 1, 2018
The promise of immunotherapy is real. We now need to figure out how to maximize the number of patients the approach benefits.
Trial Launched to Treat Parkinson’s with Reprogrammed Stem Cells
Trial Launched to Treat Parkinson’s with Reprogrammed Stem Cells
Diana Kwon | Jul 31, 2018
Surgeons will inject approximately 5 million dopamine-producing progenitor cells into patients’ brains.
Ultrasound Opens Blood-Brain Barrier in Alzheimer’s Patients
Ultrasound Opens Blood-Brain Barrier in Alzheimer’s Patients
Ashley Yeager | Jul 26, 2018
A Phase 1 clinical trial shows the noninvasive technique is safe and could aid in the delivery treatments to the brain.